Mauna Kea Technologies

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Mauna Kea Technologies sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 6 completed upper quartile by trial count

Mauna Kea Technologies: 6 sponsored US clinical trials, none currently recruiting.

Mauna Kea Technologies sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Pancreatic Cancer, with 2 trials.

Upper-quartile sponsor footprint

Mauna Kea Technologies sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

COMPLETED

Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract

NCT01770405
COMPLETED

Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung

NCT01793246
COMPLETED

pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture

NCT01392274
COMPLETED NA

CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia

NCT01032044
COMPLETED

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

NCT00779688
COMPLETED NA

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy

NCT00795184

Therapeutic Areas

Pancreatic Cancer 2
Lymph Node Mass 1
Pancreatic Islet Cell Tumors 1
Pancreatic Adenoma 1
Lymphadenopathy 1
GIST 1
Pancreatic Neoplasms 1
Bile Duct Cancer 1
Pancreatic Cyst 1

How the Mauna Kea Technologies archive is shaped

6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Pancreatic Cancer (2 trials), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Mauna Kea Technologies: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Mauna Kea Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Mauna Kea Technologies23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
Mauna Kea Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mauna Kea Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Mauna Kea Technologies page

6 registered trials is a research-attention snapshot, not an endorsement of Mauna Kea Technologies or any single study.

  • None of Mauna Kea Technologies's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pancreatic Cancer is the condition Mauna Kea Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pancreatic Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mauna Kea Technologies pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.